Efficacy and Safety of Adjunctive Zonisamide in Myoclonic Seizures Associated With Idiopathic Generalised Epilepsy
Condition(s):EpilepsyLast Updated:December 24, 2015Terminated
Hide Studies Not Open or Pending
Condition(s):EpilepsyLast Updated:December 24, 2015Terminated
Condition(s):Juvenile Myoclonic EpilepsyLast Updated:May 25, 2023Recruiting
Condition(s):Generalized Convulsive EpilepsyLast Updated:September 17, 2013Completed
Condition(s):Myoclonus Epilepsies, ProgressiveLast Updated:February 14, 2024Recruiting
Condition(s):Unverricht-Lundborg SyndromeLast Updated:March 19, 2008Unknown status
Condition(s):Epilepsy; Epilepsia; Epileptic Seizures; Seizure DisorderLast Updated:October 12, 2011Unknown status
Condition(s):EpilepsyLast Updated:July 17, 2018Completed
Condition(s):Dravet SyndromeLast Updated:April 13, 2021Completed
Condition(s):EpilepsyLast Updated:November 20, 2019Completed
Condition(s):Dravet Syndrome; Severe Myoclonic Epilepsy of InfancyLast Updated:April 14, 2022Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.